Characteristics of 114 HLA-A*02:01+ volunteer blood donors (cross-sectional study group I)
| . | All donors (n = 114) . | Nulligravidous women (n = 38) . | Primi-/ multiparous women* (n = 38) . | Men (n = 38) . |
|---|---|---|---|---|
| Age, y | ||||
| Median | 39 | 28 | 46 | 41 |
| Range | 21-63 | 21-53 | 28-63 | 21-56 |
| Serologic CMV status | ||||
| Positive | 33 | 10 | 14 | 9 |
| Negative | 73 | 27 | 17 | 29 |
| Not available | 8 | 1 | 7 | 0 |
| Receipt of a prior blood transfusion | ||||
| Yes | 2 | 0 | 1 | 1 |
| No | 112 | 38 | 37 | 37 |
| Number of pregnancies (women only) | ||||
| 0 | 38 | 38 | 0 | — |
| 1 | 10 | 0 | 10 | — |
| 2 | 18 | 0 | 18 | — |
| 3 | 6 | 0 | 6 | — |
| 4 | 3 | 0 | 3 | — |
| 5 | 1 | 0 | 1 | — |
| Current oral contraception (women only) | ||||
| Yes | 28 | 21 | 7 | — |
| No | 48 | 17 | 31 | — |
| Postmenopause (women only)† | ||||
| Yes | 7 | 1 | 6 | — |
| No | 69 | 37 | 32 | — |
| . | All donors (n = 114) . | Nulligravidous women (n = 38) . | Primi-/ multiparous women* (n = 38) . | Men (n = 38) . |
|---|---|---|---|---|
| Age, y | ||||
| Median | 39 | 28 | 46 | 41 |
| Range | 21-63 | 21-53 | 28-63 | 21-56 |
| Serologic CMV status | ||||
| Positive | 33 | 10 | 14 | 9 |
| Negative | 73 | 27 | 17 | 29 |
| Not available | 8 | 1 | 7 | 0 |
| Receipt of a prior blood transfusion | ||||
| Yes | 2 | 0 | 1 | 1 |
| No | 112 | 38 | 37 | 37 |
| Number of pregnancies (women only) | ||||
| 0 | 38 | 38 | 0 | — |
| 1 | 10 | 0 | 10 | — |
| 2 | 18 | 0 | 18 | — |
| 3 | 6 | 0 | 6 | — |
| 4 | 3 | 0 | 3 | — |
| 5 | 1 | 0 | 1 | — |
| Current oral contraception (women only) | ||||
| Yes | 28 | 21 | 7 | — |
| No | 48 | 17 | 31 | — |
| Postmenopause (women only)† | ||||
| Yes | 7 | 1 | 6 | — |
| No | 69 | 37 | 32 | — |